drugset / Trial / NCT01690351

A Study Comparing PF-05089771 TS Capsule To PF-05089771 TS Oral Dispersion In The Fasted State

NCT01690351

Phase 1 Completed 12 enrolled Pfizer
RandomizedCrossoverOpen-labelTreatment

Summary

The primary purpose of this study is to estimate the relative bioavailability and food effect of a PF-05089771 capsule.

Timeline

Start
2012-09
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-05089771 Small molecule Oral

Indications

No indication recorded.